Companies / BOC Sciences / Priliximab
BOC Sciences

Priliximab | BOC Sciences

Priliximab is a humanized monoclonal antibody that targets CD4. Priliximab has been investigated for the treatment of Crohn's disease and multiple sclerosis.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.